Chris Williams

Market Access

A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face

News

Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.